Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.1243 | 0.5 | 0.5 |
Schistosoma mansoni | brg-1 associated factor | 0.1243 | 0.5 | 0.5 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.1243 | 0.5 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.1243 | 0.5 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1243 | 0.5 | 0.5 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.1243 | 0.5 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.1243 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1243 | 0.5 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.1243 | 0.5 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.1243 | 0.5 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1243 | 0.5 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.1243 | 0.5 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1243 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1243 | 0.5 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.1243 | 0.5 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1243 | 0.5 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.1243 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1243 | 0.5 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.1243 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1243 | 0.5 | 0.5 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.1243 | 0.5 | 0.5 |
Onchocerca volvulus | 0.1243 | 0.5 | 0.5 | |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1243 | 0.5 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.1243 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IZ (functional) | = 0 mm | Antifungal activity against Candida albicans 155965 at 1 mg/ml after 48 hrs by agar-well diffusion technique | ChEMBL. | 22464424 |
IZ (functional) | = 0 mm | Antifungal activity against Saccharomyces cerevisiae 156250 at 1 mg/ml after 48 hrs by agar-well diffusion technique | ChEMBL. | 22464424 |
IZ (functional) | = 3.3 mm | Antibacterial activity against Escherichia coli 124300 at 1 mg/ml after 24 hrs by agar-well diffusion technique | ChEMBL. | 22464424 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.